|
|
|
|
Gene Activity Variations Predict Lymphoma Survival
Patterns of gene activity in a type of non-Hodgkin lymphoma has given researchers a better understanding of factors that contribute to the survival of patients treated for the disease.Gene activity, or expression, is a measure of...
|
|
|
Variations In Gene Activity Can Predict The Survival Of Patients With Lymphoma
BETHESDA, Md., Nov.28, 2008-Patterns of gene activity in a type of non-Hodgkin lymphoma has given researchers a better understanding of factors that contribute to the survival of patients treated for the disease. Gene activity, or...
|
|
|
Genes May Predict Lymphoma Treatment Outcome
WEDNESDAY, Nov.26 (HealthDay News) -- Gene activity patterns can tell doctors whether people with a certain type of non-Hodgkin lymphoma have a better chance of survival with treatment, according to a new study. Three different...
|
|
|
Genes May Predict Lymphoma Treatment Outcome
WEDNESDAY, Nov.26 (HealthDay News) -- Gene activity patterns can tell doctors whether people with a certain type of non-Hodgkin lymphoma have a better chance of survival with treatment, according to a new study. Three different...
|
|
|
Tumor Surroundings Influence Survival in Diffuse Large-B-Cell Lymphoma
BETHESDA, Md., Nov.26 -- Survival after treatment for diffuse large-B-cell lymphoma is influenced not only by the cancer, but by the tumor microenvironment, researchers here said. Gene expression profiles from pre-treatment...
|
|
|
Genes May Predict Lymphoma Treatment Outcome
WEDNESDAY, Nov.26 (HealthDay News) -- Gene activity patterns can tell doctors whether people with a certain type of non-Hodgkin lymphoma have a better chance of survival with treatment, according to a new study. Three different...
|
|
|
Genes May Predict Lymphoma Treatment Outcome
Screens might be used to determine which patients will benefit, researchers say -- Kevin McKeever WEDNESDAY, Nov.26 (HealthDay News) -- Gene activity patterns can tell doctors whether people with a certain type of non-Hodgkin lymphoma...
|
|
|
Genes May Predict Lymphoma Treatment Outcome
WEDNESDAY, Nov.26 (HealthDay News) -- Gene activity patterns can tell doctors whether people with a certain type of non-Hodgkin lymphoma have a better chance of survival with treatment, according to a new study. Three different...
National Womens Health Information Center:
Nov 27 2008 7:33AM
Matching: lymphoma diffuse
|
Find similar documents
|
|
|
|
Genes May Predict Lymphoma Treatment Outcome
Screens might be used to determine which patients will benefit, researchers say WEDNESDAY, Nov.26 (HealthDay News) -- Gene activity patterns can tell doctors whether people with a certain type of non-Hodgkin lymphoma have a better...
|
|
|
Microenvironmental Protection in Diffuse Large-B-Cell Lymphoma
_ Microenvironmental Protection in Diffuse Large-B-Cell Lymphoma.
|
|
|
Variations in Gene Activity Can Predict the Survival of Patients with Lymphoma
Patterns of gene activity in a type of non-Hodgkin lymphoma has given researchers a better understanding of factors that contribute to the survival of patients treated for the disease.Gene activity, or expression, is a measure of...
|
|
|
Genes May Predict Lymphoma Treatment Outcome
WEDNESDAY, Nov.26 (HealthDay News) -- Gene activity patterns can tell doctors whether people with a certain type of non-Hodgkin lymphoma have a better chance of survival with treatment, according to a new study. Three different...
|
|
|
Diffuse Large B-Cell Lymphoma Treatment Granted Orphan Drug Designation
The FDA has granted orphan drug status to Allos Therapeutics pralatrexat Diffuse Large B-Cell Lymphoma Treatment Granted Orphan Drug Designation.
|
|
|
U.S. FDA Grants Pralatrexate Orphan Drug Designation For The Treatment Of Patients With Diffuse Large B-Cell L
Allos Therapeutics, Inc.(Nasdaq: ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug Administration ...
|
|
|
U.S. FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Diffuse Large B-Cell L
- Allos Therapeutics, Inc.(Nasdaq: ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug...
|
|
|
Gastric Lymphoma: Studies from Medical University of Silesia, Department of Histopathology have provided new d
Studies from Medical University of Silesia, Department of Histopathology have provided new data on gastric lymphoma (NewsRx.com) -- Data detailed in 'Two cases of lymphoepithelial cyst of the pancreas: first - a cyst coexisting with a...
|
|
|
U.S. FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Diffuse Large B-Cell L
- Allos Therapeutics, Inc.(Nasdaq: ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug...
|
|
|
U.S. FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Diffuse Large B-Cell L
Allos Therapeutics, Inc.(Nasdaq: ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug Administration ...
|
|
|
U.S. FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Diffuse Large B-Cell L
WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc.(Nasdaq: ALTH - News), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced...
|
|
|
U.S. FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Diffuse Large B-Cell L
_ U.S.FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Diffuse Large B-Cell L.
|
|
|
The Ludwig pattern of androgenetic alopecia is due to a hierarchy of androgen sensitivity within follicular un
Yazdabadi A et al.- Diffuse hair loss in women with AA is due to a reduction in the number of terminal hairs per FU and an increase in the number of vellus hairs. This supports the hypothesis of a hierarchy of susceptibility...
|
|
|
The Effect of Diffuse Pulmonary Fibrosis on the Reliability of CT Signs of Pulmonary Hypertension
Devaraj A et al.- PA dilatation occurs in the absence of PH in patients with pulmonary fibrosis and is therefore an unreliable sign of PH in these patients. The Effect of Diffuse Pulmonary Fibrosis on the Reliability of CT Signs...
|
|
|
Acute Kidney Injury in a Patient with Melanuria, Diffuse Melanosis, and Metastatic Malignant Melanoma
Gambichler T et al.- The authors describe a patient with malignant melanoma, diffuse melanosis, and melanuria who developed acute kidney injury that was clinically indicated by an increase in urinary excreted metabolites in the serum.
|
|
|
Diabetic Macular Edema: What Is Focal and What Is Diffuse
Browning DJ et al.- Little evidence exists that characteristics of DME described by the terms focal and diffuse help to explain variation in visual acuity or response to treatment. It is unresolved whether a concept of focal and diffuse...
|
|
|
Evaluation of Diffuse Myocardial Fibrosis in Heart Failure With Cardiac Magnetic Resonance Contrast-Enhanced T
QJM: An International Journal of Medicine, 10/16/08 Evaluation of Diffuse Myocardial Fibrosis in Heart Failure With Cardiac Magnetic Resonance Contrast-Enhanced T.
|
